| Affymax receives $5M payment for drug development - The Associated Press |
|
|
The Associated PressThe US Phase 3 clinical program enrolled about 2600 chronic renal failure patients at approximately 400 clinical trial sites. Affymax shares fell 4 cents to ...Affymax(R) Receives $5 Million Milestone Payment on Initiation of Phase 3 ... read more |